NOVOB80 trade ideas
Novo Nordisk as of 6.12.2020My analysis of Novo Nordisk as of 6.12.2020
With the current recommendation for "buy" with my eyes (short term)
$NVO with a marginal negative earning release.$NVO posted marginal negative earning as the PEAD is projecting a slight bullish outlook for the stock with the price currently trading around the median line.
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Novo Nordisk UpdatedThe last anaylsis of Novo Nordisk was successful at its prediction. Heres an updated one of where i see it in the short term future
I Recommend SELLING Technical indicators( candles ; volume ; ligne ; fbonaci ..) indicate a decline in the market during the next week; I advise you to sell and wait for the next buying signal
Time for Novo Nordisk to break out?Let's wait and see if Novo Nordisk breaks out. Time always tells.
NVO showing weakness in short termPrice action near $57.5 will determine where it will go next.
- it has shown strength when breaking through $57.5 on larger timeframes
- NVO is a buy
- A pullback to $57.5 would be a good long entry point, provided that there are no heavy sell off during this pullback.
- new ATH likely, given some time.
Long Term: looking for an entry point on this beautiful stockNovo Nordisk is one of the world leaders in the medical treatment of diabetes.
It also researches, develops and markets treatments for obesity. It is a fast-growing sector with the rise of fast food and the development of emerging countries.
However, the field is becoming more and more competitive, especially in the US, which has meant slower growth for the future of Novo Nordisk. Until now, she was considered a "cash cow".
Let's see if I can drink her milk :-)
NVO Breakout to All-Time HighIn this chart we're looking at NVO on the 1W chart as price has consolidated into an ascending triangle . Price has broken through the horizontal boundary around $58. After price prints a 1W candle (1 day left) through $59.77 breakout will be confirmed.
This ascending triangle has a price target of around $85 for about a ~46% gain.
Price has good momentum as it has found support on the 200EMA and is breaking out of its chart pattern boundary well above the 200EMA.
If you would like to see more of these ideas on a regular basis, follow me as I will be posting many more exciting chances to earn on chart pattern breakouts this upcoming year!
Drop a like or comment if you found this idea informational or helpful in any way!
Cheers!
$NVO Breakout possible for Nova NordiskEntry level $59.50 = Target price $65.50 = Stop loss $57.60
Stock is on the verge of a multiyear breakout from 2015.
Ascending triangle formation bullish.
Odds are that the stock breaks out rather than make a triple top.
P/E ratio 23.
Company profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
Novo NordiskNovonordisk scenarios in case of 2020 recession.
Great lean healthcare giant. great long term wealth storage (10+ years)
-50% in a long recession
average 3year recovery to ath from recession or internal problems.
NVO, Novo Nordisk A/S - Potential Breakout on Ascending TriangleNYSE:NVO
Very close to the breakingout of this ascending triangle, in this case pattern of potential continuation of the trend, after a reversal already occurred in 2018.
If it were to break up, the first target would be $58.
The management of the position, the definition of the entry point and of the exit point in case of loss are what count more than anything else, also of the strategy.
finance.yahoo.com
